Cited by 552Cannabis and Cannabinoid ResearchSubstance Abuse Treatment and OutcomesSmoking Behavior and Cessation

The DOI matches its Crossref record; 340 of the 341 references it cites were found in a registry or an index.

Cannabis use and cannabis use disorder

Open access

Connor, Jason P., Stjepanović, Daniel, Le Foll, Bernard, Hoch, Eva, Budney, Alan J., Hall, Wayne D.·2021·Nature Reviews Disease Primers

DOI 10.1038/s41572-021-00247-4PMC PMC8655458

Open this paper in CoChat — free account

Abstract

Cannabis use disorder (CUD) is an underappreciated risk of using cannabis that affects ~10% of the 193 million cannabis users worldwide. The individual and public health burdens are less than those of other forms of drug use, but CUD accounts for a substantial proportion of persons seeking treatment for drug use disorders owing to the high global prevalence of cannabis use. Cognitive behavioural therapy, motivational enhancement therapy and contingency management can substantially reduce cannabis use and cannabis-related problems, but enduring abstinence is not a common outcome. No pharmacotherapies have been approved for cannabis use or CUD, although a number of drug classes (such as cannabinoid agonists) have shown promise and require more rigorous evaluation. Treatment of cannabis use and CUD is often complicated by comorbid mental health and other substance use disorders. The legalization of non-medical cannabis use in some high-income countries may increase the prevalence of CUD by making more potent cannabis products more readily available at a lower price. States that legalize medical and non-medical cannabis use should inform users about the risks of CUD and provide information on how to obtain assistance if they develop cannabis-related mental and/or physical health problems.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/s41572-021-00247-4

Cites

340 of 340 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Items 201–340 of 340

Fatty Acid Amide Hydrolase Binding in Brain of Cannabis Users: Imaging With the Novel Radiotracer [11C]CURB.
Boileau, I., Mansouri, E., Williams, B., Le Foll, B., Rusjan, P., Mizrahi, R., Tyndale, R. F., Huestis, M. A., Payer, D. E., Wilson, A. A., et al. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.04.012 · Cited by 82
Neuroimaging meta-analysis of cannabis use studies reveals convergent functional alterations in brain regions supporting cognitive control and reward processing
Yanes, J. A., Riedel, M. C., Ray, K. L., Kirkland, A. E., Bird, R. T., Boeving, E. R., Reid, M. A., González, R., Robinson, J. L., Laird, A. R., et al. (2018) · Journal of Psychopharmacology · doi:10.1177/0269881117744995 · Cited by 81
Cannabis Exposure During Critical Windows of Development: Epigenetic and Molecular Pathways Implicated in Neuropsychiatric Disease
Smith, A. R., Kaufman, F. L., Sandy, M. S., & Cárdenas, A. (2020) · Current Environmental Health Reports · doi:10.1007/s40572-020-00275-4 · Cited by 81
CNR1 gene polymorphisms in addictive disorders: a systematic review and a meta-analysis
Benyamina, A., Kébir, O., Blecha, L., Reynaud, M., & Krebs, M. (2010) · Addiction Biology · doi:10.1111/j.1369-1600.2009.00198.x · Cited by 79
The potential impact of cannabis legalization on the development of cannabis use disorders
Budney, A. J., & Borodovsky, J. T. (2017) · Preventive Medicine · doi:10.1016/j.ypmed.2017.06.034 · Cited by 79
Validation of the Cannabis Expectancy Questionnaire (CEQ) in adult cannabis users in treatment
Connor, J. P., Gullo, M. J., Feeney, G. F. X., & Young, R. M. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.10.025 · Cited by 77
User characteristics and effect profile of Butane Hash Oil: An extremely high-potency cannabis concentrate.
Chan, G. C. K., Hall, W., Freeman, T., Ferris, J., Kelly, A., & Winstock, A. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2017.04.014 · Cited by 77
Cue Reactivity in the Ventral Striatum Characterizes Heavy Cannabis Use, Whereas Reactivity in the Dorsal Striatum Mediates Dependent Use
Zhou, X., Zimmermann, K., Xin, F., Zhao, W., Derckx, R. T., Sassmannshausen, A., Scheele, D., Hurlemann, R., Weber, B., Kendrick, K. M., et al. (2019) · Biological Psychiatry: Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2019.04.006 · Cited by 77
Technology-based Interventions for Preventing and Treating Substance Use Among Youth
Marsch, L. A., & Borodovsky, J. T. (2016) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2016.06.005 · Cited by 75
The state of clinical outcome assessments for cannabis use disorder clinical trials: A review and research agenda
Loflin, M., Kiluk, B. D., Huestis, M. A., Aklin, W. M., Budney, A. J., Carroll, K. M., D’Souza, D. C., Dworkin, R. H., Gray, K. M., Hasin, D. S., et al. (2020) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2020.107993 · Cited by 75
Topiramate and motivational enhancement therapy for cannabis use among youth: a randomized placebo‐controlled pilot study
Miranda, R., Padovano, H. T., Blanchard, A., Justus, A. N., Monti, P. M., Chun, T. H., Swift, R. M., Tidey, J. W., & Gwaltney, C. J. (2016) · Addiction Biology · doi:10.1111/adb.12350 · Cited by 74
The CB1Neutral Antagonist AM4113 Retains the Therapeutic Efficacy of the Inverse Agonist Rimonabant for Nicotine Dependence and Weight Loss with Better Psychiatric Tolerability
Gueye, A. B., Pryslawsky, Y., Trigo, J. M., Poulia, N., Delis, F., Antoniou, K., Loureiro, M., Laviolette, S. R., Vemuri, K., Makriyannis, A., et al. (2016) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw068 · Cited by 74
Naltrexone Maintenance Decreases Cannabis Self-Administration and Subjective Effects in Daily Cannabis Smokers.
Haney, M., Ramesh, D., Glass, A., Pavlicova, M., Bedi, G., & Cooper, Z. D. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.108 · Cited by 73
Blockade of Nicotine and Cannabinoid Reinforcement and Relapse by a Cannabinoid CB1-Receptor Neutral Antagonist AM4113 and Inverse Agonist Rimonabant in Squirrel Monkeys.
Schindler, C. W., Redhi, G. H., Vemuri, K., Makriyannis, A., Le Foll, B., Bergman, J., Goldberg, S. R., & Justinova, Z. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.27 · Cited by 73
Prevalence, correlates and comorbidity of DSM-IV Cannabis use and Cannabis use disorders in Australia
Teesson, M., Slade, T., Swift, W., Mills, K., Memedovic, S., Mewton, L., Grove, R., Newton, N., & Hall, W. (2012) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867412460591 · Cited by 72
Self-citation
Has the Legalisation of Medical and Recreational Cannabis Use in the USA Affected the Prevalence of Cannabis Use and Cannabis Use Disorders?
Leung, J., Chiu, V., Stjepanović, D., & Hall, W. (2018) · Current Addiction Reports · doi:10.1007/s40429-018-0224-9 · Cited by 71
Are animal models of addiction useful?
Field, M., & Kersbergen, I. (2019) · Addiction · doi:10.1111/add.14764 · Cited by 69
Primary Prevention of Cannabis Use: A Systematic Review of Randomized Controlled Trials
Norberg, M. M., Kezelman, S., & Lim-Howe, N. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053187 · Cited by 68
Correlates of cannabis initiation in a longitudinal sample of young women: The importance of peer influences
Arpana Agrawal, A., Lynskey, M. T., Bucholz, K. K., Madden, P. A. F., & Heath, A. C. (2007) · Preventive Medicine · doi:10.1016/j.ypmed.2007.04.012 · Cited by 67
Psychological and psychosocial interventions for cannabis cessation in adults: a systematic review short report
Cooper, K. L., Chatters, R., Kaltenthaler, E., & Wong, R. (2015) · Health Technology Assessment · doi:10.3310/hta19560 · Cited by 63
History of cannabis use is not associated with alterations in striatal dopamine D 2 /D 3 receptor availability
Stokes, P. R., Egerton, A., Watson, B., Reid, A., Lappin, J., Howes, O. D., Nutt, D. J., & Lingford-Hughes, A. R. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881111414090 · Cited by 63
Cannabis, psychosis and schizophrenia: unravelling a complex interaction
Hamilton, I. (2017) · Addiction · doi:10.1111/add.13826 · Cited by 63
Brief Counseling for Marijuana Dependence: A Manual for Treating Adults
Steinberg, K. L., Roffman, R. A., Carroll, K. M., McRee, B. G., Babor, T. F., Miller, M. J., Kadden, R. M., Duresky, D., & Stephens, R. S. (2005) · PsycEXTRA Dataset · doi:10.1037/e436312005-001 · Cited by 62
Factors associated with the timing and onset of cannabis use and cannabis use disorder: Results from the 2007 A ustralian N ational S urvey of M ental H ealth and W ell‐ B eing
Butterworth, P., Slade, T. N., & Degenhardt, L. J. (2014) · Drug and Alcohol Review · doi:10.1111/dar.12183 · Cited by 62
Nabilone pharmacotherapy for cannabis dependence: A randomized, controlled pilot study
Hill, K. P., Palastro, M. D., Gruber, S. A., Fitzmaurice, G. M., Greenfield, S. F., Lukas, S. E., & Weiss, R. D. (2017) · American Journal on Addictions · doi:10.1111/ajad.12622 · Cited by 62
The Marijuana Screening Inventory (MSI-X): Concurrent, Convergent and Discriminant Validity with Multiple Measures
Alexander, D., & Leung, P. (2006) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990600753594 · Cited by 61
Assessment of Incorporation of Lessons From Tobacco Control in City and County Laws Regulating Legal Marijuana in California
Silver, L. D., Naprawa, A. Z., & Padon, A. A. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.8393 · Cited by 61
How to Screen for Problematic Cannabis Use in Population Surveys
Annaheim, B., Rehm, J. T., & Gmel, G. E. (2008) · European Addiction Research · doi:10.1159/000141643 · Cited by 60
Impact of age at onset of cannabis use on cannabis dependence and driving under the influence in the United States
Strat, Y. L., Dubertret, C., & Foll, B. L. (2014) · Accident Analysis & Prevention · doi:10.1016/j.aap.2014.12.015 · Cited by 59
Validation of a measure to assess alcohol- and marijuana-related risks and consequences among incarcerated adolescents☆
Stein, L. A. R., Lebeau, R., Clair, M., Rossi, J. S., Martin, R. M., & Golembeske, C. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.12.015 · Cited by 59
Medical use of cannabis products
Ablin, J. N., Ste‐Marie, P. A., Schäfer, M., Häuser, W., & Fitzcharles, M. (2016) · Der Schmerz · doi:10.1007/s00482-015-0083-4 · Cited by 59
Using polygenic scores for identifying individuals at increased risk of substance use disorders in clinical and population samples
Barr, P. B., Ksinan, A., Su, J., Johnson, E. C., Meyers, J. L., Wetherill, L., Latvala, A., Aliev, F., Chan, G., Kuperman, S., et al. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-00865-8 · Cited by 59
Striatal D2/D3 receptor availability is inversely correlated with cannabis consumption in chronic marijuana users
Albrecht, D., Skosnik, P. D., Vollmer, J. M., Brumbaugh, M. S., Perry, K. M., Mock, B. H., Zheng, Q., Federici, L. M., Patton, E. A., Herring, C. M., et al. (2012) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2012.07.016 · Cited by 58
Opioid antagonism enhances marijuana's effects in heavy marijuana smokers.
Cooper, Z. D., & Haney, M. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1875-y · Cited by 58
Demographic subgroup trends among young adults in the use of various licit and illicit drugs, 1988-2016 (Monitoring the Future Occasional Paper No. 89)
Johnston, L. D., Schulenberg, J. E., O’Malley, P. M., Bachman, J. G., Miech, R. A., & Patrick, M. (2017) · doi:10.3998/2027.42/139713 · Cited by 58
Psychosocial moderation of polygenic risk for cannabis involvement: the role of trauma exposure and frequency of religious service attendance
Meyers, J. L., Salvatore, J. E., Alıev, F., Johnson, E. C., McCutcheon, V. V., Su, J., Kuo, S. I., Lai, D., Wetherill, L. F., Wang, J. C. C., et al. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0598-z · Cited by 58
Alcohol: no ordinary commodity
Babor, T. F., Holder, H. D., Caetano, R., Homel, R. J., Casswell, S., Livingston, M., Edwards, G., Österberg, E., Giesbrecht, N., Rehm, J. T., et al. (2010) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199551149.003.002 · Cited by 58
Oculofacial‐skeletal myorhythmia in central nervous system Whipple's disease: Additional case and review of the literature
Simpson, D. A., Wishnow, R., Gargulinski, R. B., & Pawlak, A. M. (1995) · Movement Disorders · doi:10.1002/mds.870100210 · Cited by 57
Assessment of cannabis use disorders: a systematic review of screening and diagnostic instruments
López‐Pelayo, H., Batalla, A., Balcells‐Oliveró, M., Colom, J., & Gual, A. (2014) · Psychological Medicine · doi:10.1017/s0033291714002463 · Cited by 55
Cannabis Withdrawal, Posttreatment Abstinence, and Days to First Cannabis Use Among Emerging Adults in Substance Use Treatment
Davis, J. P., Smith, D. C., Morphew, J., Lei, X., & Zhang, S. (2015) · Journal of Drug Issues · doi:10.1177/0022042615616431 · Cited by 55
Media campaigns for the prevention of illicit drug use in young people
Ferri, M., Allara, E., Bò, A., Gasparrini, A., & Faggiano, F. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009287.pub2 · Cited by 54
Primary adrenocortical carcinoma causing aldosteronism
Alterman, S. L., Dominguez, C. J., Lopez-Gomez, A., & Lieber, A. L. (1969) · Cancer · doi:10.1002/1097-0142(196909)24:3 · Cited by 53
Probability and Correlates of Dependence Among Regular Users of Alcohol, Nicotine, Cannabis, and Cocaine
Cougle, J. R., Hakes, J. K., Macatee, R. J., Zvolensky, M. J., & Chavarria, J. (2016) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14m09469 · Cited by 53
1,25-Dihydroxyvitamin D3-Mediated Vesicular Transport of Calcium in Intestine: Time-Course Studies*
Nemere, I., & Norman, A. W. (1988) · Endocrinology · doi:10.1210/endo-122-6-2962 · Cited by 51
Abstinence and reduced frequency of use are associated with improvements in quality of life among treatment‐seekers with cannabis use disorder
Brezing, C., Choi, C. J., Pavlicová, M., Brooks, D., Mahony, A. L., Mariani, J. J., & LEVIN, F. R. (2018) · American Journal on Addictions · doi:10.1111/ajad.12660 · Cited by 49
Systematic review of outcome domains and measures used in psychosocial and pharmacological treatment trials for cannabis use disorder
Lee, D. C., Schlienz, N. J., Peters, E. N., Dworkin, R. H., Turk, D. C., Strain, E. C., & Vandrey, R. G. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.10.020 · Cited by 49
The Need for Federal Regulation of Marijuana Marketing
Ayers, J. W., Caputi, T. L., & Leas, E. C. (2019) · JAMA · doi:10.1001/jama.2019.4432 · Cited by 48
Massive Hemoptysis: Control by Transcatheter Bronchial Artery Embolization
Magilligan, D. J., Ravipati, S., Zayat, P., Shetty, P. C., Bower, G. C., & Kvale, P. A. (1981) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(10)61762-6 · Cited by 47
Endocannabinoid signaling in psychiatric disorders: a review of positron emission tomography studies
Sloan, M. E., Grant, C. W., Gowin, J. L., Ramchandani, V. A., & Foll, B. L. (2018) · Acta Pharmacologica Sinica · doi:10.1038/s41401-018-0081-z · Cited by 47
The relationship between cannabis outcome expectancies and cannabis refusal self‐efficacy in a treatment population
Connor, J. P., Gullo, M. J., Feeney, G. F. X., Kavanagh, D. J., & Young, R. M. (2013) · Addiction · doi:10.1111/add.12366 · Cited by 46
Genome-wide association study identifies a novel locus for cannabis dependence
Arpana Agrawal, A., Chou, Y.-L., Carey, C. E., Baranger, D. A. A., Zhang, B., Sherva, R., Wetherill, L. F., Kapoor, M., Wang, J.-C., Bertelsen, S. E., et al. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.200 · Cited by 46
Cortico-limbic circuitry for conditioned nicotine-seeking behavior in rats involves endocannabinoid signaling
Kodas, E., Cohen, C., Louis, C., & Griebel, G. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0813-0 · Cited by 45
Cannabis controversies: how genetics can inform the study of comorbidity
Arpana Agrawal, A., & Lynskey, M. T. (2014) · Addiction · doi:10.1111/add.12436 · Cited by 45
Development and validation of the Cannabis Refusal Self-Efficacy Questionnaire (CRSEQ) in adult cannabis users in treatment
Young, R. M., Gullo, M. J., Feeney, G. F. X., & Connor, J. P. (2012) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2012.02.018 · Cited by 43
Impulsivity, Variation in the Cannabinoid Receptor (CNR1) and Fatty Acid Amide Hydrolase (FAAH) Genes, and Marijuana-Related Problems
Bidwell, L. C., Metrik, J., McGeary, J. E., Palmer, R. H. C., Francazio, S. K., & Knopik, V. S. (2013) · Journal of Studies on Alcohol and Drugs · doi:10.15288/jsad.2013.74.867 · Cited by 43
Screening of cannabis-related problems among youth: the CPQ-A-S and CAST questionnaires
Fernández‐Artamendi, S., Hermida, J. R. F., Muñiz-Fernández, J., Secades‐Villa, R., & García–Fernández, G. (2012) · Substance Abuse Treatment Prevention and Policy · doi:10.1186/1747-597x-7-13 · Cited by 42
It is premature to expand access to medicinal cannabis in hopes of solving the US opioid crisis
Hall, W., West, R., Marsden, J., Humphreys, K. N., Neale, J., & Petry, N. M. (2018) · Addiction · doi:10.1111/add.14139 · Cited by 42
Quality of life and recreational cannabis use
Goldenberg, M., IsHak, W. W., & Danovitch, I. (2016) · American Journal on Addictions · doi:10.1111/ajad.12486 · Cited by 41
Recognizing and regulating cannabis as a temptation good
Caulkins, J. P. (2017) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2017.01.012 · Cited by 41
Brief Interventions for Cannabis Use in Healthcare Settings: Systematic Review and Meta-analyses of Randomized Trials
Imtiaz, S., Roerecke, M., Kurdyak, P. A., Samokhvalov, A. V., Hasan, O. S. M., & Rehm, J. T. (2019) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000527 · Cited by 41
Independent Evaluation of Middle School–Based Drug Prevention Curricula
Flynn, A. B., Falco, M., & Hocini, S. (2015) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2015.1736 · Cited by 40
Recent trends in cyclic vomiting syndrome‐associated hospitalisations with liberalisation of cannabis use in the state of Colorado
Bhandari, S., Jha, P., Lisdahl, K. M., Hillard, C. J., & Venkatesan, T. (2018) · Internal Medicine Journal · doi:10.1111/imj.14164 · Cited by 40
Cannabis Use in Adolescence: A Review of Neuroimaging Findings
Chye, Y., Christensen, E., & Yücel, M. (2019) · Journal of Dual Diagnosis · doi:10.1080/15504263.2019.1636171 · Cited by 38
Whole genome sequence study of cannabis dependence in two independent cohorts
Gizer, I. R., Bizon, C., Gilder, D. A., Ehlers, C. L., & Wilhelmsen, K. C. (2017) · Addiction Biology · doi:10.1111/adb.12489 · Cited by 36
Whole‐of‐community interventions to reduce population‐level harms arising from alcohol and other drug use: a systematic review and meta‐analysis
Stockings, E., Bartlem, K. M., Hall, A. E., Hodder, R. K., Gilligan, C., Wiggers, J., Sherker, S., & Wolfenden, L. (2018) · Addiction · doi:10.1111/add.14277 · Cited by 36
Cue-reactivity in the ventral striatum characterizes heavy cannabis use, whereas reactivity in the dorsal striatum mediates dependent usePreprint
Zhou, X., Zimmermann, K., Xin, F., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/516385 · Cited by 36
Learning and memory in the aetiopathogenesis of addiction: future implications for therapy?
von der Goltz, C., & Kiefer, F. (2009) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-009-0057-6 · Cited by 35
Building smart cannabis policy from the science up
Weiss, S. R. B., Howlett, K. D., & Baler, R. (2017) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2017.01.007 · Cited by 35
Brief school-based interventions and behavioural outcomes for substance-using adolescents
Carney, T., MYERS, B. J., Louw, J., & Okwundu, C. I. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008969.pub2 · Cited by 35
A contingency management method for 30-days abstinence in non-treatment seeking young adult cannabis users
Schuster, R. M., Hanly, A. M., Gilman, J. M., Budney, A. J., Vandrey, R. G., & Evins, A. E. (2016) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2016.08.622 · Cited by 34
Substance use: Interplay between polygenic risk and neighborhood environment
Pasman, J. A., Verweij, K. J. H., Abdellaoui, A., Hottenga, J., Fedko, I. O., Willemsen, G. A. H. M., Boomsma, D. I., & Vink, J. M. (2020) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2020.107948 · Cited by 34
Acute and residual mood and cognitive performance of young adults following smoked cannabis
Matheson, J., Mann, R. E., Sproule, B. A., Huestis, M. A., Wickens, C. M., Stoduto, G., George, T. P., Rehm, J. T., Foll, B. L., & Brands, B. (2020) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2020.172937 · Cited by 34
Effects of adolescent Δ9-tetrahydrocannabinol exposure on the behavioral effects of cocaine in adult Sprague-Dawley rats.
Friedman, A., Meurice, C., & Jutkiewicz, E. (2019) · Experimental and clinical psychopharmacology · doi:10.1037/pha0000276 · Cited by 33
Instruments to Detect Alcohol and Other Drug Misuse in the Emergency Department: A Systematic Review
Newton, A. S., Gokiert, R., Mabood, N., Ata, N., Dong, K., Ali, S., Vandermeer, B., Tjosvold, L., Hartling, L., & Wild, T. C. (2011) · Pediatrics · doi:10.1542/peds.2010-3727 · Cited by 32
Assessing problematic cannabis use
Thake, J. A., & Davis, C. G. (2011) · Addiction Research & Theory · doi:10.3109/16066359.2010.545154 · Cited by 32
Acute effects of cannabinoids on addiction endophenotypes are moderated by genes encoding the CB1 receptor and FAAH enzyme
Hindocha, C., Freeman, T. P., Schäfer, G., Gardner, C., Bloomfield, M., Bramon, E., Morgan, C. J. A., & Curran, H. V. (2019) · Addiction Biology · doi:10.1111/adb.12762 · Cited by 32
Individual-, family-, and school-level interventions targeting multiple-risk behaviours in young people
MacArthur, G. J., Kipping, R., White, J., Chittleborough, C., Lingam, R., Pasch, K. E., Gunnell, D., Hickman, M., & Campbell, R. M. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009927 · Cited by 31
Ventricular Septal Aneurysms
Edelstein, J., & CHARMS, B. L. (1965) · Circulation · doi:10.1161/01.cir.32.6.981 · Cited by 29
Cannabis Use Disorder in Adolescence.
Simpson, A., & Magid, V. (2016) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2016.03.003 · Cited by 29
Modification of the Tsivoglou method for radon daughters in air.
Thomas, J. W. (1970) · PubMed · Cited by 27
Does marijuana use have residual adverse effects on self‐reported health measures, socio‐demographics and quality of life? A monozygotic co‐twin control study in men
Eisen, S. A., Chantarujikapong, S., Xian, H., Lyons, M. J., Toomey, R., True, W. R., Scherrer, J. F., Goldberg, J. H., & Tsuang, M. T. (2002) · Addiction · doi:10.1046/j.1360-0443.2002.00120.x · Cited by 27
Naltrexone does not attenuate the effects of intravenous Δ9-tetrahydrocannabinol in healthy humans
Ranganathan, M., Carbuto, M., Braley, G., Elander, J., Perry, E. B., Pittman, B. P., Radhakrishnan, R., Sewell, R. A., & D’Souza, D. C. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711001830 · Cited by 27
A biosocial cognitive model of cannabis use in emerging adulthood
Papinczak, Z. E., Connor, J. P., Harnett, P. H., & Gullo, M. J. (2017) · Addictive Behaviors · doi:10.1016/j.addbeh.2017.08.011 · Cited by 27
Genetic Factors in Cannabinoid Use and Dependence
Mulligan, M. K. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-21737-2_7 · Cited by 27
Cannabinoid hyperemesis syndrome
Chocron, Y., Zuber, J., & Vaucher, J. (2019) · BMJ · doi:10.1136/bmj.l4336 · Cited by 26
Expression of a selectable gene transferred by a retroviral vector to hematopoietic stem cells and stromal cells in murine continuous bone marrow cultures.
Anklesaria, P. N., Sakakeeny, M. A., Klassen, V. A., Rothstein, L., FitzGerald, T. J., Appel, M., Greenberger, J. S., & Holland, C. A. (1987) · PubMed · Cited by 25
Feasibility and Preliminary Effectiveness of Varenicline for Treating Co-Occurring Cannabis and Tobacco Use
Adams, T. R., Arnsten, J. H., Ning, Y. M., & Nahvi, S. (2017) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2017.1370746 · Cited by 25
Highway to hell or magic smoke? The dose-dependence of Δ9-THC in place conditioning paradigmsPreprint
Kubilius, R. A., Kaplick, P. M., & Wotjak, C. T. (2018) · Learning & Memory · doi:10.1101/lm.046870.117 · Cited by 25
Alcohol:
Lewis, M. J. (1990) · Advances in Alcohol & Substance Abuse · doi:10.1300/j251v09n01_04 · Cited by 24
Treatment seeking in cannabis dependence: The role of social cognition
Papinczak, Z. E., Connor, J. P., Feeney, G. F. X., Young, R. M., & Gullo, M. J. (2016) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2016.11.005 · Cited by 24
Testing the biosocial cognitive model of substance use in cannabis users referred to treatment
Papinczak, Z. E., Connor, J. P., Feeney, G. F. X., Harnett, P. H., Young, R. M., & Gullo, M. J. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.09.032 · Cited by 24
Psychometric properties of the perceived stigma towards substance users scale: factor structure, internal consistency, and associations with help-seeking variables
Tuliao, A. P., & Holyoak, D. (2019) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2019.1658198 · Cited by 24
Adolescent cannabis exposure increases heroin reinforcement in rats genetically vulnerable to addiction.
Lecca, D., Scifo, A., Pisanu, A., Valentini, V., Piras, G., Sil, A., Cadoni, C., & Chiara, G. D. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.107974 · Cited by 24
Untitled work
(2019) · doi:10.1016/j.pcl.2019.08.007 · Cited by 23
The importance of psychology for shaping legal cannabis regulation.
Borodovsky, J. T., Sofis, M. J., Grucza, R. A., & Budney, A. J. (2020) · Experimental and Clinical Psychopharmacology · doi:10.1037/pha0000362 · Cited by 23
Alcohol burden in low-income and middle-income countries
Connor, J. P., & Hall, W. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00236-6 · Cited by 22
Psychosocial and Pharmacological Interventions for the Treatment of Cannabis Use Disorder
Sabioni, P., & Foll, B. L. (2019) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.17202 · Cited by 22
Classics in Neuroimaging: Imaging the Endocannabinoid Pathway with PET
Varlow, C., Boileau, I., Wey, H., Liang, S. H., & Vasdev, N. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00305 · Cited by 22
The psychiatric inpatient treatment of children and youth in general hospitals
Kiesler, C. A., Simpkins, C. G., & Morton, T. L. (1989) · American Journal of Community Psychology · doi:10.1007/bf00922740 · Cited by 21
Brief Interventions for Cannabis Use Disorders: A Review
Parmar, A., & Sarkar, S. (2017) · Addictive Disorders & Their Treatment · doi:10.1097/adt.0000000000000100 · Cited by 21
Epigenetic Effects of Drugs of Abuse
Heinbockel, T., & Csoka, A. B. (2018) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph15102098 · Cited by 21
The Age of Onset of Substance Use Disorders
Kelly, A. B., Weier, M., & Hall, W. (2018) · Springer eBooks · doi:10.1007/978-3-319-72619-9_8 · Cited by 21
Blunts versus joints: Cannabis use characteristics and consequences among treatment-seeking adults
Montgomery, L., McClure, E. A., Tomko, R. L., Sonne, S. C., Winhusen, T. M., Terry, G. E., Grossman, J. T., & Gray, K. M. (2019) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2019.01.041 · Cited by 19
Screening Medications for the Treatment of Cannabis Use Disorder
Panlilio, L. V., Justinová, Z., Trigo, J. M., & Foll, B. L. (2016) · International review of neurobiology · doi:10.1016/bs.irn.2016.02.005 · Cited by 18
Predictors of Topiramate Tolerability in Heavy Cannabis–Using Adolescents and Young Adults: A Secondary Analysis of a Randomized, Double-Blind, Placebo-Controlled Trial
Gray, J. C., Treloar Padovano, H., Wemm, S. E., & Miranda, R. (2018) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000843 · Cited by 18
Chronic Δ9-THC in Rhesus Monkeys: Effects on Cognitive Performance and Dopamine D2/D3 Receptor Availability
John, W. S., Martin, T. J., Sai, K. K. S., Nader, S. H., Gage, H. D., Mintz, A., & Nader, M. A. (2017) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.117.244194 · Cited by 17
Pharmacotherapies for Cannabis Use Disorders: Clinical Challenges and Promising Therapeutic Agents
Nielsen, S., Sabioni, P., Gowing, L., & Foll, B. L. (2019) · Handbook of experimental pharmacology · doi:10.1007/164_2019_258 · Cited by 17
Relationships between marijuana use, severity of marijuana-related problems, and health-related quality of life
Liao, J., Mooney, L. J., Zhu, Y., Valdez, J., Yoo, C. K., & Hser, Y. (2019) · Psychiatry Research · doi:10.1016/j.psychres.2019.03.010 · Cited by 16
Open-label pilot study of injectable naltrexone for cannabis dependence
Notzon, D. P., Kelly, M. A., Choi, C. J., Pavlicová, M., Mahony, A. L., Brooks, D. J., Mariani, J. J., & LEVIN, F. R. (2018) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2017.1423321 · Cited by 15
What do we know about the pharmacotheraputic management of insomnia in cannabis withdrawal: A systematic review
Zhand, N., & Milin, R. (2018) · American Journal on Addictions · doi:10.1111/ajad.12783 · Cited by 15
Several clock genes polymorphisms are meaningful risk factors in the development and severity of cannabis addiction
Saffroy, R., Lafaye, G., Desterke, C., Ortiz‐Tudela, E., Amirouche, A., Innominato, P. F., Pham, P., Benyamina, A., & Lemoine, A. (2018) · Chronobiology International · doi:10.1080/07420528.2018.1523797 · Cited by 14
State Legalization of Recreational Marijuana: Selected Legal Issues
Garvey, T., & Yeh, B. T. (2013) · University of North Texas Digital Library (University of North Texas) · Cited by 13
Overlap of heritable influences between cannabis use disorder, frequency of use and opportunity to use cannabis: trivariate twin modelling and implications for genetic design
Hines, L. A., Morley, K. I., Rijsdijk, F. V., Strang, J., Arpana Agrawal, A., Nelson, E. C., Statham, D. J., Martin, N. G., & Lynskey, M. T. (2018) · Psychological Medicine · doi:10.1017/s0033291718000478 · Cited by 13
When and How to Treat Possible Cannabis Use Disorder
Lévesque, A., & Foll, B. L. (2018) · Medical Clinics of North America · doi:10.1016/j.mcna.2018.02.009 · Cited by 13
A theory of addiction
West, R., & Brown, J. (2013) · Wiley eBooks · doi:10.1002/9781118484890.ch9 · Cited by 12
Early Developmental Stages of Substance Abuse and Dependence
Wïttchen, H., Lieb, R., & Perkonigg, A. (1999) · KARGER eBooks · doi:10.1159/000059546 · Cited by 11
Brief school-based interventions and behavioural outcomes for substance-using adolescents
Carney, T., MYERS, B. J., Louw, J., & Okwundu, C. I. (2014) · Advances in Psychiatric Treatment · doi:10.1192/apt.20.3.154 · Cited by 11
Smoke screen: America's drug policy and medical marijuana.
Conboy, J. R. (2000) · PubMed · Cited by 9
Physical aspects of total body irradiation of bone marrow transplant patients using 18 MV X rays
Niroomand‐Rad, A. (1991) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(91)90077-h · Cited by 7
[Plasma and tissue concentrations of biphenylacetic acid following 1 week oral fenbufen medication and topical administration of Felbinac gel on the knee joint].
Bolten, W. W., Salzmann, G., Goldmann, R., & Miehlke, K. (1989) · PubMed · Cited by 6
Physical training of moderate intensity improves survival rate of diabetic rats submitted to experimental myocardial infarction.
Dompierre, H., Rousseau-Migneron, S., Tancrède, G., & Nadeau, A. (1990) · PubMed · Cited by 5
[Percutaneous dilatation of recurrent coarctation of the aorta in the 1st year of life].
Piéchaud, J.-F., Delogu, A. B., Kachaner, J., Iserin, L., Aggoun, Y., Bonnet, D., & Sidi, D. (1995) · PubMed · Cited by 4
[The indoor environment and disease symptoms. An evaluation of conditions in schools in Copenhagen].
Kk, I., Valbjørn, O., & Nielsen, A. K. (1981) · PubMed · Cited by 4
What physicians should know about the regulation of Obstetric and Gynecologic Medical Devices.
Yin, L. (1983) · PubMed · Cited by 3
Highly purified agarose as stacking gel in sodium dodecyl sulphate/polyacrylamide-gel electrophoresis
Aasted, B. (1980) · Biochemical Journal · doi:10.1042/bj1890183 · Cited by 3
Genetic Aspects of Cannabis Use Disorder
Blecha, L., Lafaye, G., & Benyamina, A. (2018) · Springer eBooks · doi:10.1007/978-3-319-90365-1_3 · Cited by 3
The effects of training-testing interval and intellectual level upon transposition.
Butterfield, G. B., & Ec, B. (1968) · PubMed · Cited by 2
CANDIS Program: Modular Treatment of Cannabis Use Disorders
Hoch, E., & Rohrbacher, H. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-800756-3.00130-7 · Cited by 2
Microcomputer analysis of indicator dilution curves to determine qp/qs
Latson, L. A., Balyeat, E., & Lewis, R. L. (1984) · Catheterization and Cardiovascular Diagnosis · doi:10.1002/ccd.1810100417 · Cited by 1
[Air-gun injuries in the maxillofacial region].
Matić, V., & Ivanovic, A. M. (1974) · PubMed · Cited by 1
[Expenses generated by 4 patients with tetanus in the Tarragona province and economic possibilities in regard to prevention].
Espinàs, J. A., & Rm, S. (1989) · PubMed · Cited by 1
[Renal autotransplantation and ex vivo surgery in renal calculus disease].
Ohshima, S., Ono, Y., Kinukawa, T., Matsuura, O., Takeuchi, N., & Hattori, R. (1984) · PubMed · Cited by 1
[Effect of disconnecting the cortical and subcortical areas of the rabbit brain on spatial organization of cortical bioelectric activity].
Knipst, I. N., Vn, B., & Tishaninova, L. V. (1972) · PubMed · Cited by 1
[Differential diagnosis of roentgenological round formations in the lungs].
Barkov, V. A. (1966) · PubMed · Cited by 1
Familiar infantile haemochromatosis.
DIAZ, C. J., Perianes, J., Jl, P., Villares, E. S., Jm, L., & Villalobos, E. (1964) · PubMed · Cited by 1
[The antiarrhythmic drug Etmozine in the light of new findings].
Mádle, A. (1987) · PubMed · Cited by 1
[Myeloradiculography with iopamidol and metrizamide. Comparative study].
Bohutová, J., Kolár, J., & Lerlová, L. (1984) · PubMed · Cited by 1
[Modalities of startle suppression: explorations of the bulbar medulla oblongata].
Lamarche, M. (1968) · PubMed · Cited by 1
The Quest of Candidate Gene in Alcohol Dependence
Lee, S.-Y., Chang, Y.-H., & Lu, R. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800213-1.00050-x · Cited by 1
[The SR Ivotray oral impression method for orthodontic models].
Zierleyn, I. (1968) · PubMed · Cited by 1

Research works printed but not linked: 13

Hall, W., Renström, M. & Poznyak, V. The Health and Social Effects of Nonmedical Cannabis Use (World Health Organization, 2016). This is a seminal review of the short-term and long-term effects of cannabis use and CUD on health.
National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Population Health and Public Health Practice, & Committee on the Health Effects of Marijuana: An Evidence Review and Research Agenda. The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research (National Academies Press, 2017).
Compton, W. M. & Han, B. in The Complex Connection between Cannabis and Schizophrenia (eds Compton, M. & Manseau, M.) (Academic Press, 2017).
Connor, J. P., Feeney, G. F. X., Kelly, A. B. & Saunders, J. B. in The SAGE Handbook of Drug & Alcohol Studies. Volume 2, 283–305 (SAGE Publications, 2016).
Howlett, A. C. in Cannabinoids. Handbook of Experimental Psychology, vol 168 (ed. Pertwee, R. G.) 53–79. (Springer, 2005).
Trick, L. et al. in PET and SPECT in Psychiatry 2nd edn (eds Dierckx, R. A. J. O., Otte, A., de Vries, E. F. J., van Waarde, A. & Sommer, I. E.) 653–712 (Springer, 2020).
McMurran, M. The Psychology of Addiction (Routledge, 1994).
American Psychiatric Association. Substance-related and addictive disorders. in Diagnostic and Statistical Manual of Mental Disorders (American Psychiatric Association, 2013). · DOI · Paper page
Connor, J. P., Saunders, J. B. & Feeney, G. F. X. in Quality of Life in Mental Disorders (eds Katschnig, H., Freeman, H. L. & Sartorius, N.) 199–208 (John Wiley & Sons, 2006).
Longabaugh, R., Magill, M., Morgenstern, J. & Huebner, R. in Addictions: A Comprehensive Guidebook (eds McCrady, B. S. & Epstein, E. E.) 572–596 (Oxford University Press, 2013).
Marlatt, G. A., & Donovan, D. M. (eds) Relapse Prevention: Maintenance Strategies in the Treatment of Addictive Behaviors (Guilford Press, 1985).
Saunders, J. B. et al. (eds) Addiction Medicine (Oxford University Press, 2016).
Ries, N. M. Prescribe with caution: the response of canada’s medical regulatory authorities to the therapeutic use of cannabis. McGill J. Law Health 9, 215–254 (2016).

Sorted by citations

Balancing risks and benefits of cannabis use: umbrella review of meta-analyses of randomised controlled trials and observational studies
Solmi, M., Toffol, M. D., Kim, J. Y., Choi, M., Stubbs, B., Thompson, T., Firth, J., Miola, A., Croatto, G., Baggio, F., et al. (2023) · BMJ · doi:10.1136/bmj-2022-072348 · Cited by 322
Immune Influencers in Action: Metabolites and Enzymes of the Tryptophan-Kynurenine Metabolic Pathway
Tanaka, M., Tóth, F., Polyák, H., Szabó, Á., Mándi, Y., & Vécsei, L. (2021) · Biomedicines · doi:10.3390/biomedicines9070734 · Cited by 259
Public health monitoring of cannabis use in Europe: prevalence of use, cannabis potency, and treatment rates
Manthey, J., Freeman, T. P., Kilian, C., López‐Pelayo, H., & Rehm, J. T. (2021) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2021.100227 · Cited by 184
Recreational cannabis legalization alters associations among cannabis use, perception of risk, and cannabis use disorder treatment for adolescents and young adults
Mennis, J. L., McKeon, T. P., & Stahler, G. J. (2022) · Addictive Behaviors · doi:10.1016/j.addbeh.2022.107552 · Cited by 131
Therapeutic effect of psilocybin in addiction: A systematic review
van der Meer, P. B., Fuentes, J. J., Kaptein, A. A., Schoones, J. W., de Waal, M. M., Goudriaan, A. E., Kramers, K., Schellekens, A., Somers, M., Bossong, M. G., et al. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1134454 · Cited by 127

See all 552

Authors: Connor, J. P., Stjepanović, D., Le Foll, B., Hoch, E., Budney, A. J., & Hall, W. D.
Affiliations: The University of Queensland (AU)
LMU Klinikum (DE)
Dartmouth College (US)
Corresponding author: Connor, Jason P.
ORCID: Connor, Jason P.
Stjepanović, Daniel
Budney, Alan J.
Hall, Wayne D.
Venue: Nature Reviews Disease Primers
Publisher: Springer Science and Business Media LLC
Published: 2021-02-25
Volume: 7
Issue: 1
Pages: 16-16
ISSN: 2056-676X (ISSN-L)
DOI: 10.1038/s41572-021-00247-4
PMC: PMC8655458
OpenAlex: W3131397527
Cited by: 552
References: 341
Citations by year: 2026: 106 · 2025: 135 · 2024: 119 · 2023: 122 · 2022: 49 · 2021: 21
FWCI: 9.85
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springernature.com/gp/researchers/text-and-data-mining (tdm)
www.springernature.com/gp/researchers/text-and-data-mining (vor)
Locations: Nature Reviews Disease Primers (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institute on Drug Abuse (R01DA050032, T32DA037202, P30DA029926)
Topics: Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
Keywords: cannabis use disorder, cannabis use, cognitive behavioral therapy, motivational enhancement therapy, contingency management, abstinence, cannabinoid receptor agonists, pharmacotherapy, psychiatric comorbidity, substance use disorders, cannabis legalization, medical cannabis, non-medical cannabis, public health burden
MeSH terms: Analgesics, Cannabis, Marijuana Abuse, Humans, Cognitive Behavioral Therapy, Prevalence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cannabis use and cannabis use disorder

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks